What Is Neuroprotection?
Featured ArticleMain Category: Stroke
Also Included In: Neurology / Neuroscience; Parkinson's Disease; Multiple Sclerosis
Article Date: 09 Oct 2006 - 9:00 PDT
| Patient / Public: | ![]() |
4.2 (10 votes) |
| Healthcare Prof: | ![]() |
3.9 (10 votes) |
| Article Opinions: | 1 posts |
Neuroprotection is the mechanisms and strategies used to protect against neuronal injury or degeneration in the Central Nervous System (CNS) following acute disorders (e.g. stroke or nervous system injury/trauma) or as a result of chronic neurodegenerative diseases (e.g. Parkinson's, Alzheimer's, Multiple Sclerosis).
The goal of neuroprotection is to limit neuronal dysfunction/death after CNS injury and attempt to maintain the highest possible integrity of cellular interactions in the brain resulting in an undisturbed neural function.
There is a wide range of neuroprotection products available or under investigation and some products can potentially be used in more than one disorder, as many of the underlying mechanisms of damage to neural tissues (in both acute disorders and in chronic neurodegenerative diseases) are similar. Products with neuroprotective effects are grouped into the following categories:
-- Free radical trappers/scavengers
-- Anti-excitotoxic agents
-- Apoptosis (programmed cell death) inhibitors
-- Anti-inflammatory agents
-- Neurotrophic factors
-- Metal ion chelators
-- Ion channel modulators
-- Gene therapy
Medical News Today is pleased to announce the launch of a new information resource dedicated to raising awareness of the role of neuroprotection in Acute Ischemic Stroke (AIS).
The National Stroke Association states that stroke is the number one cause of adult disability in America (66% of survivors having some type of disability) - there are an estimated 15 million strokes occurring worldwide each year.
The new section details the cascade of events following AIS and the effects of neuroprotection on outcomes.
Written by: Peter Hill
Medical News Today
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/articles/53700.php>
APA
http://www.medicalnewstoday.com/articles/53700.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Neuroprotection
posted by cosar on 30 Aug 2011 at 4:23 pmI am a PD sufferer, would appreciate to read more about the theme.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




